Methionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics

Journal of Nutrition

Volumn 126, Issue 1, 1996, Pages 67-75

  Ehlers, Katharine ^a   Elmazar, Mohamed M A ^b   Nau, Heinz ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

methionine; mice; pharmacokinetics; spina bifida; valproic acid

Indexed keywords

METHIONINE; SODIUM CHLORIDE; TERATOGENIC AGENT; VALPROIC ACID;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; EMBRYO; EMBRYOTOXICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; SPINA BIFIDA; SUBCUTANEOUS DRUG ADMINISTRATION; TERATOGENICITY;

EID: 0030045586     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/126.1.67     Document Type: Article

References (32)

1. Bjerkedal, T. A., Czeizel, A., Goujard, J., Kallen, B., Mastroiacova, P., Nevin, N., Oakley, G. & Robert, E. (1982) Valproic acid and spina bifida. Lancet II: 1096.
2. Bolton, S. (1984) Pharmaceutical Statistics, pp. 133-135, 147-151. Marcel Dekker Inc., New York, NY.
3. Campbell, L. R., Dayton, D. H. & Sohal, G. S. (1986) Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. Teratology 34: 171-187.
4. Coelho, C.N.D. & Klein, N. W. (1990) Methionine and neural tube closure in cultured rat embryos: morphological and biochemical analyses. Teratology 42: 437-451.
5. Coelho, C.N.D., Weber, J A., Klein, N. W., Daniels, W. G. & Hoagland, T. A. (1989) Cultured rat embryos require methionine for neural tube closure. J. Nutr. 119: 1716-1725.
6. Copp, A. J., Brook, F. A., Estibeiro, J. P., Shum, A.S.W. & Cockroft, D. L. (1990) The embryonic development of mammalian neural tube defects. Prog. Neurobiol. 35: 363-403.
7. Czeizel, A. E. & Dudas, I. (1992) Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl J. Med. 227: 1832-1835.
8. Ehlers, K., Stürje, H., Merker, H.-J. & Nau, H. (1992a) Valproic acid-induced spina bifida: a mouse model. Teratology 45: 145-154.
9. Ehlers, K., Stürje, H., Merker, H.-J & Nau, H. (1992b) Spina bifida aperta induced by valproic acid and by all-trans-retinoic acid in the mouse: distinct differences in morphology and periods of sensitivity. Teratology 46: 117-130.
10. 12 on valproic acid-induced teratogenesis in mice. Fundam. Appl. Toxicol 18: 389-394.
11. Essien, F. B. (1992) Maternal methionine supplementation promotes the remediation of axial defects in Axd mouse neural tube mutants. Teratology 45: 205-212.
12. 12 alters the frequency of neural tube defects in Axd mutant mice. J. Nutr. 123: 27-33.
13. Finkelstein, J. D. (1990) Methionine metabolism in mammals. J. Nutr. Biochem. 1: 228-237.
14. Fisher, E., Wittfoht, W. & Nau, H. (1992) Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry. Biomed. Chromatogr. 6: 24-29
15. Kao, J., Brown, N. A., Schmid, B., Goulding, E. H. & Fabro, S. (1981) Teratogenicity of valproic acid: in vivo and in vitro investigations. Teratog. Carcinog. Mutagen. 1:367-382.
16. Koch, S., Jag̈er-Roman, E., Rating, D. & Helge, H. (1983) Possible teratogenic effect of valproate during pregnancy. J. Pediatr. 103: 1007.
17. Laurence, K. M., James, N., Miller, M. & Campbell, H. (1980) Increased risk of recurrence of pregnancy complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counseling. Br. Med. J. 281: 1592-1594.
18. Laurence, K. M., James, N., Miller, M., Tennent, G. B. & Campbell, H. (1981) Double-blind randomized controlled trials of folate treatment before conception to prevent recurrence of neural tube defects. Br. Med. J. 282: 1509-1511.
19. Lindhout, D. & Meinardi, H. (1984) Spina bifida and in-utero exposure to valproate. Lancet II: 396.
20. Lindhout, D. & Omtzigt, J.G.C. (1994) Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia 35 (Suppl. 4): 19-28.
21. Lindhout, D. & Schmidt, D. (1986) In utero exposure to valproate and neural tube defects. Lancet I: 1392-1393.
22. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338: 131-137.
23. Nau, H., Hauck, R.-S. & Ehlers, K. (1991) Valproic acid-induced neural tube defects in mouse and human; aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol. Toxicol. 69: 310-321.
24. Nosel, P. G. & Klein, N. W. (1992) Methionine decreases the embryotoxicity of sodium valproate in the rat: in vivo and in vitro observations. Teratology 46: 499-507.
25. Robert, E. & Rosa, F. (1983) Valproate and birth defects. Lancet II: 1142.
26. Scott, J. M., Weir, D. G., Molloy, A., McPartlin, J. & Kirke, P (1994) Folic acid metabolism and mechanisms of neural tube defects. In: Neural Tube Defects (Bock, G. & Marsh, J., eds.), pp. 180-191. Wiley, Chichester, England.
27. Smithells, R. W., Sheppard, S., Schorah, C. J., Seller, M. J., Nevin, N. C., Harris, R., Read, A. P. & Fielding, D. W. (1980) Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet I: 339-340.
28. Steegers-Theunissen, R.P.M., Boers, G.H.J., Trijbels, F.J.M. & Eskes, T.K.A.B. (1991) Neural tube defects and derangement of homocysteine metabolism. N. Engl. J. Med. 324: 199-200.
29. Trotz, M., Wegner, W. & Nau, H. (1987) Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse. Life Sci. 41: 103-110.
30. Turner, S., Sucheston, M. E., de Philipp, R. M. & Paulson, R. B. (1990) Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate. Teratology 41: 421-442.
31. Wassersug, R. L. (1976) A procedure for different staining of cartilage and bone in whole formol-fixed vertebrates. Stain. Technol. 51: 131-134.
32. Wegner, C. & Nau, H. (1992) Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology 42 (Suppl. 5): 17-24.